Author

Anuhar Chaturvedi

BioNTech (Germany)ORCID 0000-0002-9597-3010Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:multiome· 1 Organism:non-human primate· 1

Frequent Co-Authors

Uğur ŞahiniD· 2 shared Alexandra MalziD· 1 shared Anja KoppiD· 1 shared Annette B. VogeliD· 1 shared Candice Morin· 1 shared Charles L. DulbergeriD· 1 shared Christiane StadleriD· 1 shared Felix TolksdorfiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Uğur ŞahinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyMolecular Therapy — Nucleic AcidsPeer-reviewedSep 17, 2026

RNA-Encoded PGT121-LS Anti-HIV Antibody: Comprehensive Preclinical Characterization and Translational Pharmacokinetics

Felix Tolksdorf, Johannes Nelke, Robin Johannson…·Valentin Le Douce

This paper presents an RNA-encoded bNAb platform for in vivo production of PGT121-LS, showing prolonged half-life and potent neutralization in mice and non-human primates.

DOI 10.1016/j.omtn.2026.103102

non-human primateexperimental assay

𝕏 PostBluesky

ImmunologyNature ImmunologyPeer-reviewedJun 12, 2026

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well-tolerated and efficacious in rodent models

Neha Agrawal, Louis S. Ates, Stefan A. Schille…·Uğur Şahin

This paper describes two mRNA vaccines for tuberculosis that are immunogenic, well-tolerated, and effective in rodent models, entering clinical trials.

9 citationstop 1%

mouserat

𝕏 PostBluesky